Fixed-dose tablets merging sulfonylurea gliclazide and metformin for treating type 2 diabetes mellitus. Supplied by pharmaceutical producers to bulk buyers including hospital chains and drug distributors, facilitating procurement for primary care physicians in community health centers and private practices.